Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
Omeros (OMER) Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
-
UPDATE: HUTCHMED (China) (HCM) and Viatris (VTRS) Top Cantor Fitzgerald's List of Biggest Short Interest Increases, Heron (HRTX) and Omeros (OMER) Continue to Have Higher Short Floats
-
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases
-
Omeros Corp. (OMER) PT Lowered to $20 at Cantor Fitzgerald
-
VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List
-
Pre-Open Stock Movers 12/02: (CFVI) (OMER) (DWAC) Higher; (TANH) (KIRK) (LE) Lower (more...)
-
CRL is a Negative, but Omeros (OMER) Stock is Trading Far Below Fundamental Value - Analyst
-
Omeros Corp. (OMER) CRL Not a Surprise, Stock Cheap - Cantor Fitzgerald
-
Omeros (OMER) Announces Pricing of Public Offerings of Common Stock, Convertible Notes
-
Omeros Announces Pricing of Public Offerings
-
Omeros Announces Full Exercise and Closing of Underwriter’s Option to Purchase Additional Shares
-
Omeros (OMER) Prices $50M Upsized Share Offering at $13.10/Sh
-
Omeros Announces Pricing of Upsized Public Offering of Common Stock
-
Omeros (OMER) to Offer Common Stock
-
Omeros Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Starts Omeros Corp. (OMER) at Overweight
-
Omeros (OMER) Prices $210 Million Offering of Convertible Senior Notes Due 2023
-
Omeros Announces Pricing of $210 Million Offering of Convertible Senior Notes Due 2023
-
Omeros (OMER) Proposed $210 Million Offering of Convertible Senior Notes Due 2023
-
Omeros Announces Proposed $210 Million Offering of Convertible Senior Notes Due 2023
-
Omeros Closes $68.3 Million Public Offering of Common Stock
-
Pre-Open Movers 08/15: (EXTR) (SYF) (P) (SNAP) (DKS) (AAP) (COH) (more)
-
Omeros (OMER) Prices 3M Common Stock Offering at $22.75/Share
-
Omeros Announces Pricing of Public Offering of Common Stock
-
Omeros (OMER) Commences 3M Common Stock Offering
-
Omeros Announces Public Offering of Common Stock
-
Cantor Fitzgerald Maintains Neutral & $15 PT on Omeros (OMER) Following 'Breakthrough Therapy Designation Provides Validation for OMS721 in IgA Nephropathy'
-
Pre-Open Stock Movers 05/17: (RRGB) (JACK) (TGT) Higher; (BEBE) (PLUG) (XLRN) Lower (more...)
-
Cantor Fitzgerald Downgrades Omeros Corp. (OMER) to Neutral
-
Cantor Fitzgerald Reiterates Overweight on Omeros (OMER) Following 4Q
-
Omeros (OMER): Reiterating $21 PT On Solid Prelim Phase II Data - Cantor Fitzgerald
-
Omeros (OMER) Prices $40M Common Stock Offering at $11.50/Share
-
Omeros Announces Pricing of Public Offering of Common Stock
-
Omeros (OMER) to Offer $40M in Common Stock
-
Omeros Announces Public Offering of Common Stock
-
Omeros to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Cantor Fitzgerald Starts Omeros Corp. (OMER) at Buy

